Philadelphia Trust Company’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-2,250
| Closed | -$315K | – | 259 |
|
|
2025
Q3 | $315K | Hold |
2,250
| – | – | 0.02% | 200 |
|
|
2025
Q2 | $283K | Hold |
2,250
| – | – | 0.02% | 203 |
|
|
2025
Q1 | $308K | Buy |
2,250
+250
| +13% | +$35.7K | 0.03% | 196 |
|
|
2024
Q4 | $306K | Hold |
2,000
| – | – | 0.02% | 197 |
|
|
2024
Q3 | $388K | Buy |
+2,000
| New | +$418K | 0.03% | 179 |
|
|
2021
Q4 | – | Sell |
-2,630
| Closed | -$744K | – | 229 |
|
|
2021
Q3 | $744K | Hold |
2,630
| – | – | 0.05% | 146 |
|
|
2021
Q2 | $911K | Sell |
2,630
-41,867
| -94% | -$12.7M | 0.06% | 141 |
|
|
2021
Q1 | $12.4M | Buy |
44,497
+2
| +0% | +$539 | 0.96% | 36 |
|
|
2020
Q4 | $10.9M | Sell |
44,495
-185
| -0.4% | -$47.7K | 0.89% | 34 |
|
|
2020
Q3 | $12.7M | Buy |
44,680
+1,068
| +2% | +$298K | 1.22% | 25 |
|
|
2020
Q2 | $11.7M | Sell |
43,612
-9,194
| -17% | -$2.76M | 1.23% | 27 |
|
|
2020
Q1 | $16.7M | Sell |
52,806
-2,334
| -4% | -$708K | 2.11% | 18 |
|
|
2019
Q4 | $16.4M | Sell |
55,140
-18,642
| -25% | -$5.17M | 1.4% | 25 |
|
|
2019
Q3 | $17.2M | Sell |
73,782
-4,588
| -6% | -$1.07M | 1.59% | 20 |
|
|
2019
Q2 | $18.3M | Sell |
78,370
-3,044
| -4% | -$703K | 1.61% | 18 |
|
|
2019
Q1 | $19.2M | Buy |
81,414
+6,634
| +9% | +$2.09M | 1.7% | 18 |
|
|
2018
Q4 | $22.5M | Sell |
74,780
-3,275
| -4% | -$1.05M | 2.4% | 11 |
|
|
2018
Q3 | $27.6M | Sell |
78,055
-4,128
| -5% | -$1.42M | 2.26% | 14 |
|
|
2018
Q2 | $23.9M | Sell |
82,183
-11,879
| -13% | -$3.34M | 2.13% | 13 |
|
|
2018
Q1 | $25.8M | Sell |
94,062
-6,001
| -6% | -$1.86M | 2.14% | 15 |
|
|
2017
Q4 | $31.9M | Sell |
100,063
-525
| -0.5% | -$168K | 2.51% | 12 |
|
|
2017
Q3 | $31.5M | Buy |
100,588
+5,308
| +6% | +$1.57M | 2.59% | 8 |
|
|
2017
Q2 | $25.9M | Buy |
95,280
+11,004
| +13% | +$2.91M | 2.2% | 12 |
|
|
2017
Q1 | $23M | Sell |
84,276
-7,648
| -8% | -$2.16M | 1.89% | 14 |
|
|
2016
Q4 | $26.1M | Sell |
91,924
-1,709
| -2% | -$507K | 2.08% | 10 |
|
|
2016
Q3 | $29.3M | Sell |
93,633
-7,987
| -8% | -$2.37M | 2.53% | 7 |
|
|
2016
Q2 | $24.6M | Sell |
101,620
-3,623
| -3% | -$955K | 2.13% | 12 |
|
|
2016
Q1 | $27.4M | Buy |
105,243
+6,839
| +7% | +$1.81M | 2.35% | 12 |
|
|
2015
Q4 | $29.4M | Buy |
98,404
+4,212
| +4% | +$1.21M | 2.46% | 8 |
|
|
2015
Q3 | $27.5M | Buy |
94,192
+74,518
| +379% | +$24.6M | 2.48% | 7 |
|
|
2015
Q2 | $48.7K | Sell |
19,674
-16,416
| -45% | -$6.59M | 0.18% | 85 |
|
|
2015
Q1 | $15.2M | Buy |
36,090
+8,445
| +31% | +$3.33M | 1.16% | 39 |
|
|
2014
Q4 | $9.38M | Buy |
27,645
+26,577
| +2,488% | +$8.6M | 0.75% | 46 |
|
|
2014
Q3 | $353K | Buy |
1,068
+25
| +2% | +$8.24K | 0.02% | 139 |
|
|
2014
Q2 | $329K | Hold |
1,043
| – | – | 0.02% | 144 |
|
|
2014
Q1 | $319K | Sell |
1,043
-15
| -1% | -$4.76K | 0.02% | 153 |
|
|
2013
Q4 | $296K | Sell |
1,058
-25
| -2% | -$6.47K | 0.02% | 170 |
|
|
2013
Q3 | $261K | Buy |
+1,083
| New | +$242K | 0.02% | 166 |
|
Other funds holding BIIB
Philadelphia Trust Company's BIIB Position: Q4 2025 in Review
Philadelphia Trust Company sold out of Biogen (BIIB) in Q4 2025, closing a stake of 2,250 shares — an estimated $315K sold.
Philadelphia Trust Company first reported a position in BIIB in Q3 2013 and held it in 38 quarters. The position peaked at $31.9M in Q4 2017. 997 funds tracked by Wall St. Rank hold BIIB as of Q4 2025.
- Philadelphia Trust Company reported no remaining Biogen position as of Q4 2025 after selling out during the quarter.
- Philadelphia Trust Company sold 2,250 Biogen shares in Q4 2025, an estimated $315K.
- Philadelphia Trust Company first reported a position in Biogen in Q3 2013 and held it in 38 quarters.
- Philadelphia Trust Company's Biogen position peaked at $31.9M in Q4 2017.
- 997 funds tracked by Wall St. Rank held Biogen as of Q4 2025.
Based on Philadelphia Trust Company's 13F filing for Q4 2025, filed 12 Feb 2026.